IBP vs LEVI

IBP presents a dichotomy of elite operational efficiency and concerning valuation/insider signals. While the Piotroski F-Score of 4/9 indicates stable health and the company boasts a superior ROE of 37.51% compared to its sector, the stock trades at a massive premium to its Graham Number ($76.02). Earnings growth remains strong (18.20% YoY) despite stagnant revenue growth (-0.40%), suggesting internal cost optimizations rather than market expansion. The primary headwind is a starkly bearish insider sentiment, highlighted by the CEO selling 400,000 shares.

LEVI presents a compelling growth-at-a-reasonable-price (GARP) opportunity, anchored by a stable Piotroski F-Score of 4/9 and a current price ($22.30) that sits comfortably below its growth-based intrinsic value of $40.12. While the Graham Number suggests a lower defensive floor of $13.25, the company's exceptional ROE of 25.41% and strong earnings growth (32.6% YoY) justify a premium. Despite bearish insider sentiment and a weak technical trend, the fundamental trajectory is supported by consistent earnings beats and a P/E ratio significantly lower than the sector average.